NCT01607905 2023-01-26Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor CancerKaryopharm Therapeutics IncPhase 1 Completed192 enrolled 29 charts
NCT02283359 2016-01-15Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal EsophagusH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Terminated3 enrolled